- Home
- CMPX vs LSAK Comparison
CMPX vs LSAK Comparison
Compare CMPX & LSAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- LSAK
- Stock Information
- Founded
- CMPX 2014
- LSAK 1997
- Country
- CMPX United States
- LSAK South Africa
- Employees
- CMPX N/A
- LSAK N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- LSAK Investment Bankers/Brokers/Service
- Sector
- CMPX Health Care
- LSAK Finance
- Exchange
- CMPX Nasdaq
- LSAK Nasdaq
- Market Cap
- CMPX 291.8M
- LSAK 344.5M
- IPO Year
- CMPX N/A
- LSAK N/A
- Fundamental
- Price
- CMPX $3.20
- LSAK $4.57
- Analyst Decision
- CMPX Strong Buy
- LSAK
- Analyst Count
- CMPX 9
- LSAK 0
- Target Price
- CMPX $12.67
- LSAK N/A
- AVG Volume (30 Days)
- CMPX 729.4K
- LSAK 29.0K
- Earning Date
- CMPX 08-11-2025
- LSAK 09-03-2025
- Dividend Yield
- CMPX N/A
- LSAK N/A
- EPS Growth
- CMPX N/A
- LSAK N/A
- EPS
- CMPX N/A
- LSAK N/A
- Revenue
- CMPX $850,000.00
- LSAK $574,080,000.00
- Revenue This Year
- CMPX N/A
- LSAK $1.06
- Revenue Next Year
- CMPX N/A
- LSAK $13.32
- P/E Ratio
- CMPX N/A
- LSAK N/A
- Revenue Growth
- CMPX N/A
- LSAK 4.13
- 52 Week Low
- CMPX $0.87
- LSAK $3.39
- 52 Week High
- CMPX $4.08
- LSAK $5.60
- Technical
- Relative Strength Index (RSI)
- CMPX 64.53
- LSAK 55.99
- Support Level
- CMPX $3.11
- LSAK $4.03
- Resistance Level
- CMPX $3.45
- LSAK $4.70
- Average True Range (ATR)
- CMPX 0.20
- LSAK 0.23
- MACD
- CMPX 0.01
- LSAK -0.03
- Stochastic Oscillator
- CMPX 69.33
- LSAK 75.00
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About LSAK Lesaka Technologies Inc.
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.